FIELD: medicine.
SUBSTANCE: invention relates to novel peptides, compositions which are intended for treating neurodegenerative diseases, for example, Alzheimer's disease.
EFFECT: treating neurodegenerative diseases.
11 cl, 21 dwg, 2 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODY, WHICH RECOGNIZES PEPTIDE T14 ACHE | 2016 |
|
RU2729491C2 |
| MODIFIED PEPTIDES FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2017 |
|
RU2756052C2 |
| CYCLIC C-TERMINAL PEPTIDE OF ACETYLCHOLINESTERASE IN TREATING OR PREVENTING CANCER OR METASTASIS | 2015 |
|
RU2711161C2 |
| CANCER | 2017 |
|
RU2783416C2 |
| APPLICATION OF ANTIBODY AGAINST AMYLOID-BETA IN CASE OF EYE DISEASES | 2008 |
|
RU2571859C2 |
| METHOD OF USE IN THERAPY | 2010 |
|
RU2579659C2 |
| USING ANTI-AMYLOID BETA ANTIBODY IN OPHTHALMIC DISEASES | 2008 |
|
RU2542967C2 |
| USING ANTI-AMYLOID BETA ANTIBODY IN OPHTHALMIC DISEASES | 2008 |
|
RU2604181C2 |
| HUMANISED ANTIBODY | 2008 |
|
RU2538709C2 |
| METHOD OF TREATING ALZHEIMER'S DISEASE | 2004 |
|
RU2385161C2 |
